Thromboelastographic analysis of patients receiving aprotinin with comparisons to platelet aggregation and other assays.
Koza
M J
MJ
Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Walenga
J M
JM
Khenkina
Y N
YN
Sullivan
H J
HJ
Montoya
A
A
Pifarre
R
R
D007611:Aprotinin / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D007692:Diatomaceous Earth / Q000494:pharmacology; D006490:Hemostatics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D016343:Monitoring, Intraoperative / Q000379:methods*; D010974:Platelet Aggregation / Q000187:drug effects*; D010978:Platelet Factor 4 / Q000032:analysis; D010979:Platelet Function Tests; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D012086:Reoperation
D006490:Hemostatics; D010978:Platelet Factor 4; D007692:Diatomaceous Earth; D007611:Aprotinin